France· FR:69610664
RUKOBIA 600 mg, comprimé à libération prolongée
A medicinal product containing trométhamine de fostemsavir, registered in France by VIIV HEALTHCARE (PAYS-BAS), on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- TROMÉTHAMINE DE FOSTEMSAVIR
- Manufacturer
- VIIV HEALTHCARE (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009302202901 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 60 comprimé(s)EUR 3.39
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trométhamine de fostemsavir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandRukobiaViiV Healthcare BV
- CzechiaRUKOBIAViiV Healthcare BV, Amersfoort
- SwitzerlandRukobia 600 mg, RetardtablettenViiV Healthcare GmbH
- SpainRUKOBIA 600 MG COMPRIMIDOS DE LIBERACION PROLONGADAViiv Healthcare B.V.
- United KingdomRukobia 600mg modified-release tabletsViiV Healthcare UK Ltd
- IrelandRukobia 600 mg prolonged-release tabletsViiV Healthcare BV
- IcelandRukobiaViiV Healthcare BV
- NetherlandsRukobia 600 mg tabletten met verlengde afgifteViiV healthcare B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rukobia
- Liechtenstein · Rukobia
- Norway · Rukobia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/947ddd76-3ade-4140-a195-a1f743f67ac2 GET /v1/drugs/947ddd76-3ade-4140-a195-a1f743f67ac2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69610664",
"date_amm": "2021-02-04",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/20/1518",
"substance": "TROMÉTHAMINE DE FOSTEMSAVIR",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé à libération prolongée",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about trométhamine de fostemsavir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.